Skip to main content


Fig. 2 | Critical Care

Fig. 2

From: Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options

Fig. 2

An approach to the treatment of vasoplegia. Non-catecholamine agents should be started at low doses, followed by non-catecholamine agents, including vasopressin and methylene blue. Use of hydroxocobalamin and/or angiotensin II should be considered with increasing doses of catecholamines. Clinical judgment should guide avoidance of certain agents if there is undue risk of side effects. All agents can be associated with intolerance, and discontinuation of offending agent(s) should be made accordingly

Back to article page